Skip to main content

Table 2 Outlines of periodic assessments of study participants

From: Cost effectiveness of different screening strategies for gestational diabetes mellitus screening: study protocol of a randomized community non-inferiority trial

 

Method or sample used

> 14 week

14–19 week

20–23 week

24–30 week

31–34 week

35–37 week

38 week

39 week

40 week

Birth

28 days after birth

Maternala,b

 Past medical, reproductive and obstetrics history

 Weight

Calibrated scale

a

a

a

a

a

a

a

a

a

  

 Height

Stadiometer

a

          

 Blood pressure (systolic, diastolic)

Calibrated mercury sphygmomanometer

a

a

a

a

a

a

a

a

a

  

 Fundal height

Measuring tape

 

a

a

a

a

a

a

a

a

  

 Fetal heart rate

  

a

a

a

a

a

a

a

a

  

 Fetal ultrasound

 

a

  

a

 

a

     

 FPG

Venous sample

a

          

 OGTT-75 g or GCT following OGTT-100 g

Venous sample

   

a

       

 Quality of life

Questionnaire

 

a

a

a

a

 

a

    

 Drug adherence

Questionnaire

 

a

a

a

a

 

a

    

 GDM treatment satisfaction

Questionnaire

 

a

a

a

a

 

a

    

 Cost-effectiveness

Questionnaire

 

a

a

a

a

 

a

  

a

 

 Feto-maternal outcomesc

          

a

 

Neonatala,b

 C-peptide

Cord sample

         

a

 

 Weight

Calibrated baby scale

         

a

 

 Recumbent length

Infantometer

         

a

 

 Head circumference

Measuring tape

         

a

 

 Blood glucosee

Heel-stick sample

         

a

 

 Neonatal outcomesd

          

a

a

  1. aData collected from routine and expert scans that occur during the time points
  2. bIf GDM or other complication were diagnosed, subsequent additional visits, measurements and standard treatment were performed
  3. cFeto-maternal outcomes continuously recoded include abortion, gestational hypertension, pre-eclampsia/eclampsia, preterm birth, instrumental delivery, primary cesarean section, polyhydramnios, oligohydramnios, premature rupture of membrane, placenta Previa, placenta abruption, postpartum hemorrhage, wound and incision infection
  4. dNeonatal outcomes include shoulder dystocia, intrauterine growth restriction, macrosomia, Apgar score, neonatal hypoglycemia, neonatal hypocalcemia, neonatal hyperbilirubinemia, polycythemia, neonatal intensive care unit admission, neonatal care unit admission, Respiratory distress syndrome, congenital anomaly, neonatal asphyxia, intrauterine fetal death, perinatal death, Erb–Duchenne palsy, birth trauma, neonatal sepsis
  5. eMeasured for high risk groups